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HIV-1 can infect T cells by cell-free virus or by direct
virion transfer between cells through cell contact-
induced structures called virological synapses (VS).
During VS-mediated infection, virions accumulate
within target cell endosomes. We show that after
crossing the VS, the transferred virus undergoes
both maturation and viral membrane fusion.
Following VS transfer, viral membrane fusion occurs
with delayed kinetics and transferred virions display
reduced sensitivity to patient antisera compared to
mature, cell-free virus. Furthermore, particle fusion
requires that the transferred virions undergo proteo-
lytic maturation within acceptor cell endosomes,
which occurs over several hours. Rapid, live cell
confocal microscopy demonstrated that viral fusion
can occur in compartments that have moved away
from the VS. Thus, HIV particle maturation activates
viral fusion in target CD4+ T cell endosomes
following transfer across the VS and may represent
a pathway by which HIV evades antibody neutraliza-
tion.
INTRODUCTION
During acute HIV-1 infection, patients experience a high-plasma
viremia that is partially controlled by a vigorous but ultimately
inadequate cellular and humoral immune response. Antibodies
that can neutralize cell-free virus are detected in patient sera,
but generally are ineffective against contemporaneous viral
isolates circulating in patients (Frost et al., 2008). How HIV-1
replication persists in the face of a vigorous immune response
remains a perplexing and important question. Although most
studies have focused on cell-free viral infection, direct cell-cell
transfer of HIV-1 is more efficient and can resist neutralizationCell Host &by patient antibodies (Chen et al., 2007; Hu¨bner et al., 2009).
Direct HIV-1 spread from T cell to T cell occurs through intercel-
lular adhesive structures known as virological synapses (VS)
(Blanco et al., 2004; Chen et al., 2007; Jolly et al., 2004). VS
formation is initiated when the viral envelope (Env) on the surface
of an infected (donor) cell interacts with CD4 on an uninfected
(acceptor) cell. Stabilization of the synapse requires Env/CD4
interactions, a dynamic cytoskeleton, and membrane choles-
terol (Jolly et al., 2007b). In addition, integrins, tyrosine kinases,
and tetraspanin proteins accumulate at the VS (Jolly et al.,
2007a; Rudnicka et al., 2009; Sol-Foulon et al., 2007). These
studies show that adhesion and cell signaling are important in
mediating highly efficient HIV-1 dissemination from infected
donor cells to acceptor CD4+ cells.
Following VS formation, the bulk of virus is transferred over
several hours, resulting in the accumulation of virus in internal
endocytic compartments of the acceptor cell (Hu¨bner et al.,
2009). However, the capacity of this intracellular virus to induce
fusion has not been examined. HIV-1 fusion is pH-independent.
Early studies with cell-free virus indicated that fusion did not
require endocytosis and was likely to occur predominantly at
the plasma membrane (Maddon et al., 1988; Stein et al., 1987).
More recent studies have indicated that the endosomal
compartment may play a significant role in promoting viral entry.
Inhibition of the endocytic apparatus by expressing the domi-
nant-negative forms of eps15 or dynamin reduced cell-free viral
infection by 40%–80% (Daecke et al., 2005). More recently,
Miyauchi et al. have used peptide inhibitors and live cell imaging
to demonstrate that cell-free HIV-1 fusion occurs prominently in
endosomes (Miyauchi et al., 2009).
Here, we use a combination of flow cytometry and fluores-
cence microscopy to demonstrate that HIV-1 particles undergo
viral membrane fusion following transfer across the VS. We
unexpectedly found that cell-mediated viral fusion occurs with
a substantial kinetic delay compared to cell-free virus. Detailed
analysis using immunostaining and viral mutants demonstrated
that HIV-1 particles transfer across the VS in an immature form
and then mature within the endosome. Furthermore, we find
that viral maturation plays an essential regulatory role inMicrobe 10, 551–562, December 15, 2011 ª2011 Elsevier Inc. 551
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Figure 1. Cell-Cell Transfer of HIV-1
Promotes Efficient Viral Fusion with
Kinetics that Are Distinct from Cell-free
Virus
(A–D) The CD4+CXCR4+ T cell line MT4 was
incubated with either 30 ng (150 ng/ml) of HIV-
1/Vpr-BlaM cell-free virus particles (A), Jurkat cells
expressing HIV-1/Vpr-BlaM (B), or Jurkat cells
expressing HIV-1/Vpr-BlaM separated by a
porous membrane that is permeable to virus yet
impermeable to T cells (C). After incubation for the
indicated amount of time, viral fusionwas detected
by the fluorescence shift associated with cleavage
of the BLaM substrate CCF2-AM as described in
Experimental Procedures. Representative FACS
plots are shown in (A–C) and a time course is
shown in (D). Results in (A–C) are representative of
four independent experiments. Data in (D) are
results from a representative experiment, done in
triplicate and depicting the mean fusion for each
time point ± SEM after subtracting from back-
ground values (left column, A–C). See also Fig-
ure S1.
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Endosomal HIV Fusion after Virological Synapseactivating viral membrane fusion within this intracellular
compartment. Our results support a model whereby the
activation of Env fusogenicity occurs primarily within the T cell
endosome and may sequester key fusogenic epitopes from
recognition by neutralizing antibodies.
RESULTS
Cell-Cell Transfer of HIV-1 Promotes Efficient Viral
Fusion with Kinetics and Inhibitor Sensitivity that
Are Distinct from Cell-free Virus
To study the ability of HIV-1 particles to induce viral membrane
fusion after internalization through the VS, we employed the
Vpr-b-lactamase (Vpr-BlaM) enzymatic assay for measuring viral
fusion (Cavrois et al., 2002; Mu¨nk et al., 2002). In this assay,552 Cell Host & Microbe 10, 551–562, December 15, 2011 ª2011 Elsevier Inc.expression of Vpr-BlaM in HIV-infected
cells results in packaging the enzyme
into nascent virus particles. Fusion of
these particles with substrate-loaded
target cells releases the enzyme into the
cytoplasm, where the sequestered BlaM
substrate is cleaved. Detection of the
cleaved substrate by flow cytometry
provides an indicator of viral fusion
activity. We first measured the ability of
high-titer, cell-free virus, which was
produced by transfection of 293T cells,
to initiate viral membrane fusion with
CD4+ T cells. We note that the levels of
cell-free virus that produce a robust
fluorescence shift are typically 50- to
100-fold higher than that released from
transfected Jurkat cells during a routine
4–8 hr coculture experiment. When MT4,
a highly permissive T cell line, wasexposed to cell-free Vpr-BlaM HIV-1, we detected viral fusion
activity in 5%–10% of cells as a fluorescence wavelength shift
using flow cytometry (Figure 1A).
To measure viral membrane fusion following cell-to-cell trans-
fer of HIV-1, we used Jurkat T cells, cotransfected with pNL4-3/
Vpr-BlaM, as HIV-expressing donor cells. These cells were co-
cultured with DDAO Far Red-labeled MT4 cells and viral fusion
activity was similarly detected in the T cell line (Figure 1B). Sepa-
ration of the donor and acceptor cells with a porous membrane
that is permeable to virus but impermeable to the MT4 cells
reduced fusion activity to background levels, suggesting that
cell contact or close proximity was required (Figure 1C). Interest-
ingly, BlaM activity in target cells increased faster following
exposure to cell-free virus compared to cell-associated virus.
Fusion of cell-free virus was rapid; approximately 50% of
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Figure 2. Viral Fusion in Target Cells after Exposure to Cell-free and
Cell-Associated Virus Exhibit Distinct Sensitivities to Patient Sera
MT4 cells were incubated with either 30 ng (150 ng/ml) of HIV-1/Vpr-BlaM viral
particles (cell-free) or Jurkat cells expressing HIV-1/Vpr-BlaM (cell-cell). After
a 6 hr coculture, viral fusion was assessed with the BLaM substrate CCF2-AM
as described in the Experimental Procedures.
(A) Control fusion assay treated with vehicle (DMSO) alone.
(B) Fusion assay treated with fusion antagonist AMD3100.
(C) Fusion assay treated with neutralizing nonimmune antisera.
(D and E) (D) Fusion assay treated with control patient antisera.
Representative FACS plots are shown in (A–D) and a summary of data pooled
from five independent experiments is shown in (E). All data was corrected for
a background of 0.4% and normalized to control conditions. Data in (E)
represent mean ± SEM (n = 5). *p < 0.05; **p < 0.01; ***p < 0.001.
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Cell Host &maximal fusion activity occurred within 2 hr and greater than
80% of all fusion occurred within 4 hr (Figure 1D). In contrast,
the kinetics of fusion following transfer across the VS was
comparatively slow, with only approximately 10% of maximal
fusion activity occurring within the first 2 hr and less than 50%
of maximal fusion activity was observed within 4 hr (Figure 1D).
In addition to measuring viral membrane fusion activity with
the CD4+ T cell line, MT4, as the VS-target cell (Figure 1), we
also observed viral membrane fusion activity after exposure
of primary CD4+ T cells to either cell-free or cell-associated
HIV-1 (Figure S1).
We next sought to test the ability of patient sera and a fusion
inhibitor to block viral fusion after exposure to cell-free and
cell-associated HIV-1. As expected, the CXCR4-targeted fusion
antagonist AMD3100 was able to block viral membrane fusion
from both cell-free virus and VS-transferred HIV-1 (Figures 2B
and 2E). Importantly, AMD3100 does not affect the bulk, CD4-
dependent transfer of HIV-1 between T cells (Chen et al.,
2007). We have previously demonstrated that patient sera that
neutralize 90%–100% of cell-free infection can have little or no
effect on the bulk transfer of HIV-1 particles from T cell to
T cell (Chen et al., 2007). At the same concentration, the same
patient sera are capable of blocking only 40%–50% of cell-
mediated productive infection (Hu¨bner et al., 2009). Here,
employing the Vpr-BlaM assay, we found that polyclonal
patient sera at a 1:50 dilution was able to block nearly 100%
of cell-free viral fusion but only approximately 50% of viral
fusion following transfer across the VS (Figures 2C and 2E).
Control human sera had no inhibitory effect on viral fusion
induced by either cell-free or cell-associated virus at this
concentration (Figures 2D and 2E). Taken together, these results
suggest that a polyclonal mixture of HIV-1 antibodies is less
effective at blocking viral fusion when the virus transfers across
a synapse.
The ability of Env to mediate viral membrane fusion is regu-
lated by the maturation state of the virus particle (Jiang and
Aiken, 2007; Murakami et al., 2004; Murakami and Freed,
2000; Wyma et al., 2004). Immature viral particles were reported
to be poorly fusogenic, and cleavage of the Gag protein corre-
lated with enhanced fusion activity. To determine whether the
delay in fusion kinetics of cell-associatedHIV-1 reflects a require-
ment for particle maturation, we used the HIV-1 protease inhib-
itor Indinavir (IDV) to disrupt the viral maturation process. IDV
had little effect on the fusion induced by mature cell-free virus
(Figures 3B and 3D). This was expected because virus harvested
from transfected 293T cells (typically at 48 hr post-transfection)
is for the most part already fully processed and should not be
sensitive to protease inhibitors (Hu¨bner et al., 2007). Surprisingly,
IDV blocked 70% of viral fusion following infection with cell-
associated HIV-1 (Figures 3B and 3D). The requirement for viral
protease activity in viral fusion during both cell-free and cell-
mediated infection is further supported by the observation that
protease-deficient viral mutants were unable to mediate fusion
(Figure S2A).
To control for the possibility that the incorporation and/or
maximal activity of BlaM in viral particles may require viral
protease, we used pNL4-3 MA/p6, a pNL4-3 clone that not
only has wild-type protease but also carries Gag mutations
that prevent its cleavage by HIV-1 protease (Wyma et al.,Microbe 10, 551–562, December 15, 2011 ª2011 Elsevier Inc. 553
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Figure 3. Viral Fusion in Target Cells after Exposure to Cell-free and
Cell-Associated Virus Exhibits Distinct Sensitivities to Protease
Inhibitor
Fusion assays were performed as in Figure 2.
(A) Control fusion assay treated with vehicle (DMSO) alone.
(B) Fusion assay treated with Indinavir, an HIV protease inhibitor.
(C) Fusion assay performed using a mutant virus with MA-p6a, a noncleavable
Gag. Reprentative FACS plots are shown in (A-C), (D) A summary of data
pooled from five independent experiments is shown. Data in (D) represent
mean ± SEM (n = 5). *p < 0.05; **p < 0.01; ***p < 0.001.
All data were corrected for a background of 0.4% and normalized to control
conditions. See also Figure S2.
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Endosomal HIV Fusion after Virological Synapse2004). The pNL4-3 MA/p6 virus produced viral particles with
efficiency similar to that of wild-type virus but the particles did
not undergo maturation (Figure S2B). Both cell-free and cell-
mediated viral fusion assays with pNL4-3 MA/p6 confirmed
that cleavage of Gag by viral protease was essential for viral
fusion after infection with cell-free or cell-associated HIV-1554 Cell Host & Microbe 10, 551–562, December 15, 2011 ª2011 Els(Figures 3C and 3D). Consistent with our viral fusion data, we
found that IDV inhibited productive infection by coculture with
cell-associated HIV-1 but not by exposure to mature cell-free
virus that had already undergone proteolytic maturation
(Figure S2C).
The Virological Synapse Promotes the Transfer
of Immature Viral Particles to Acceptor Cells, Where
They Undergo Protease-Dependent Maturation
Multiple factors could partially account for the kinetic delay
seen in VS-promoted fusion, including the time that it takes to
form cell-cell contacts. However, the requirement for viral
protease in viral membrane fusion (Figures 3B–D and S2A) sug-
gested to us that HIV-1 particles are transferred to CD4+ T cells
in an immature state and subsequently undergo maturation
within target cell endosomes over a period of hours. Impor-
tantly, published pulse-chase studies have demonstrated that
full HIV-1 viral maturation takes place over time periods up to
8 hr (Pettit et al., 1994). To test whether viral maturation could
occur in intracellular compartments of acceptor cells following
transfer across the VS, we monitored particle maturation
following transfer across the VS with a monoclonal antibody
that recognizes cleaved p17 but not the p55 Gag precursor
(Ono et al., 2000; Zhou and Resh, 1996). Jurkat T cells trans-
fected with HIV Gag-iGFP, a GFP-tagged infectious clone of
HIV-1, were mixed with uninfected Far Red-labeled primary
CD4+ cells. Monitoring the GFP and anti-p17-phycoerythrin
(PE) signals in the Far Red-labeled acceptor cells allowed us
to simultaneously monitor the transfer and maturation of virus
following transfer across the VS. As assessed by the
percentage of acceptor CD4+ T cells with a GFP signal, cell-
cell transfer of HIV-1 was efficient and nearly achieved a steady
state at 4 hr. For example, 40.8% of acceptor cells were GFP+
at 4 hr and 44.8% of acceptor cells were positive at 8 hr
(Figures 4B and 4F). During this time frame, the fraction of
p17+ cells increased modestly (from 11.0% to 13.9%) and
only a fraction of the cells that took up virus showed strong
intracellular p17 staining (Figures 4B and 4G). In stark contrast,
cells treated with AMD3100 showed an increase in p17 staining
(from 18.9% to 36.7%) over this time period, providing
evidence of maturing virus within cell confines (Figures 4C
and 4G). Thus, blocking fusion with AMD3100 enhanced the
accumulation of mature virus particles in acceptor cells. IDV
blocked the accumulation of cleaved p17 in acceptor cells at
all time points (Figures 4D and 4G), confirming the specificity
of this monoclonal antibody. Likewise, examination of a
protease-deficient virus revealed no accumulation of p17
(Figures 4E and 4G). Thus, accumulation of mature virus in
intracellular compartments was completely dependent upon
HIV-1 protease and was further increased by preventing viral
fusion. To rule out the effect of the Gag-iGFP on particle matu-
ration, we also conducted the same maturation experiments
with a non-GFP tagged wild-type virus and demonstrated viral
maturation in acceptor cells with kinetics similar to the HIV-
Gag-iGFP virus (Figure S3). Combined with the kinetic data
shown in Figure 1, these data strongly suggest that HIV-1
undergoes protease-dependent maturation over a period of
hours following transfer across the VS and before undergoing
viral membrane fusion.evier Inc.
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Figure 4. HIV-1 Undergoes Maturation in
Acceptor Cells over Time Following Trans-
fer across the Virological Synapse
Jurkat T cells were transfected with HIV Gag-iGFP
and mixed with Far Red-labeled primary CD4+
cells as described in Experimental Procedures.
At the indicated times, cells were permeabilized
and stained with a monoclonal antibody that
recognizes the viral protein p17 only in the context
of mature virus. Representative FACS plots illus-
trate the total virus transferred and the mature
virus transferred at 4 or 8 hr.
(A) Primary CD4+ target cells after mixture with
untransfected Jurkat cells.
(B) HIV-1 cell-cell transfer and maturation assays
treated with vehicle (DMSO) alone.
(C) Assay conducted in the presence of fusion
antagonist AMD3100.
(D) Assay conducted in the presence of Indinavir
(IDV), a protease inhibitor.
(E) Assays performed with a viral mutant carrying
a mutation in the catalytic site of protease, Pr(-).
(F) Time course of virus transfer.
(G) Time course of virus maturation. Data in (F) and
(G) are results from a representative experiment
done in triplicate, depicting the mean values ±
SEM. In all conditions, SEM < 1 and is smaller
than the symbol size. Time course experiments are
representative of four independent experiments.
See also Figure S3.
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Endosomal HIV Fusion after Virological SynapseProtease-Dependent Maturation Occurs in an
Intracellular Compartment Following Transfer across
the Virological Synapse
To determinewhere in the target cell thematuration of virus parti-
cles takes place, we developed an additional maturation assay
that is based upon fluorescence resonance energy transfer
(FRET). We used HIV Gag-iGFP and HIV Gag-iCherry, which
respectively carry GFP or Cherry fluorescent protein fused inter-Cell Host & Microbe 10, 551–562, December 15, 2011 ª2011 Elsevier Inc. 555r
rnally into Gag. Because GFP and Cherry
can function as a donor acceptor FRET
pair, the FRET signal between these
fluorophores provides a measure of
Gag-Gag interactions (Hu¨bner et al.,
2007). In a dual-labeled immature viral
particle, fluorophores are packed within
a Gag lattice that generates a maximum
FRET signal (Figure 5A). Because GFP in
Gag-iGFP is flanked by protease recog-
nition sites, it is cleaved apart from the
Gag polypeptides during the maturation
process, releasing it from the constraints
of a tight Gag lattice (Hu¨bner et al., 2007).
Thus, the level of FRET in mature viral
particles would likely be lower than in
immature particles. We tested this first
by examining viral particles that had
been produced in 293T cells by cotrans-
fection of HIV Gag-iGFP and HIV Gag-
iCherry. Blocking the virus maturation
process, either by using a protease-defi-
cient virus or treating producer cells withIDV, significantly enhanced viral particle FRET (Figures 5B and
5C). We then used these observations to directly test ou
hypothesis that viral maturation takes place in intracellula
compartments of acceptor CD4+ T cells. Jurkat T cells were
cotransfected with HIV Gag-iGFP and HIV Gag-iCherry and
mixed with primary CD4+ T cells. Cocultures were incubated
at 37C for 2–5 hr prior to imaging by confocal microscopy
(Figures 5D and 5E). After particles were transferred across
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Figure 5. Following Transfer across the Virological Synapse, HIV-1 Virions Undergo Maturation in Intracellular Compartments
(A) Diagram depicting the arrangement of fluorescent monomers in viral particles made from HIV Gag-iGFP and HIV Gag-iCherry. FRET is predicted to be highest
in immature particles and lower following cleavage at protease sites during maturation.
(B and C) 293T cells were cotransfected with HIV Gag-iGFP and HIV Gag-iCherry at a 1:1 ratio (n = 1,400). Viral particles were harvested and imaged as described
in Experimental Procedures. The distribution of nFRET values for the particles is shown in (B) and the mean nFRET values for each condition is shown in (C).
(D–F) Jurkat T cells were cotransfected with HIV Gag-iGFP and HIV Gag-iCherry at a 1:1 ratio and mixed with CellTracker Blue-labeled primary CD4+ T cells for 2
or 5 hr in the presence of AMD3100. Cells were fixed and imaged as described in Experimental Procedures. A representative acceptor cell is shown in (D and E),
and the quantification of particle nFRET values (n = 60) in acceptor cells following coculture is shown in (F).
Data in (B), (C), and (F) are from single experiments that were each representative of three independent experiments. (C) and (F) are represented as an exper-
imental mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
Cell Host & Microbe
Endosomal HIV Fusion after Virological SynapseVS, they exhibited a time-dependent decrease in nFRET from 2
to 5 hr, consistent with progressive Gag processing over time
(Figure 5F). Target cells treated with IDV showed no change in
nFRET over time, suggesting that the loss of nFRET that we
observed is dependent on viral protease activity (Figure 5F).
These results suggest that the particle maturation seen in
acceptor cells takes place in an endocytic compartment.
HIV-1 Fusion Can Occur within an Intracellular
Compartment Following Transfer across the Virological
Synapse
We next sought to further examine how and where viral particles
transferred across the VS into endosomes may undergo viral
membrane fusion. We made use of the fact that HIV Vpr associ-
ates with the viral core following viral membrane fusion (Fassati
and Goff, 2001). Infection of cells with virus that has packaged556 Cell Host & Microbe 10, 551–562, December 15, 2011 ª2011 Elsa GFP-Vpr fusion protein enables one to track the movement
of the viral core through the cytoplasm to the nucleus (McDonald
et al., 2002). We generated dual-labeled (HIV Gag-iCherry and
GFP-Vpr) fluorescent virus that served as a real-time reporter
of viral fusion. Because the Cherry molecule cleaves away
from Gag during particle maturation (Hu¨bner et al., 2007), we
expect that a fusion event is characterized by the Cherry signal’s
loss of colocalization with GFP-Vpr, due to the release of the
contents of the viral particle. Thus, during a fusion event,
a dual-labeled (yellow) particle undergoes a loss of Cherry signal
associated with the GFP-VPR associated core (Figures 6A and
6D). A similar labeling strategy that generates fluorescent protein
cleaved from Gag protein has been employed to monitor HIV
fusion in HeLa CD4+ T cells (MA-GFP-CA virus, (Miyauchi
et al., 2009)). We validated our approach by producing HIV
Gag-iCherry/GFP-Vpr particles from 293T cells and incubatingevier Inc.
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Endosomal HIV Fusion after Virological Synapsethem with HeLa CD4+ cells, allowing viral membrane fusion to
proceed for 2 hr at 37C. Quantitative confocal imaging of the
cells allowed us to assess the relative intensity of GFP and
Cherry in viral puncta, which may represent individual or small
clusters of viral particles. In a typical control experiment, approx-
imately 1,400 viral particles are identified by the presence of
a GFP-Vpr signal using an automated image segmentation algo-
rithm, and themeanCherry fluorescence associatedwith each of
these particles was calculated (Figures 6B and 6C). In the pres-
ence of AMD3100, the mean Cherry particle fluorescence was
21% greater than that in the control conditions (Figure 6C).
This result is consistent with AMD3100-sensitive fusion events
occurring in the HeLa target cells.
In addition to observing a change in the mean fluorescence of
all viral puncta, we observed a shift of some individual viral
puncta to a lower level of mean red fluorescence compared to
cells treated with AMD3100. This was especially notable when
examining particles with a lower GFP signal, which more likely
may represent single particles. In control conditions, 6.7% of
puncta were found to be low in Cherry fluorescence compared
to 1.1% in those treated with AMD3100 (Figure 6B). This analysis
suggests that we may be able to detect some fusion events that
lose nearly the entire Cherry signal.
To determine if viral fusion can be detected in individual parti-
cles following viral transfer across the VS, Jurkat T cells were
cotransfected with HIV Gag-iCherry and GFP-Vpr and cocul-
tured with primary CD4+ cells in the presence or absence of
AMD3100. Importantly, under these conditions HIV-1 is predom-
inantly intracellular, as assessed by trypsin sensitivity or
antibody accessibility (Chen et al., 2007; Hu¨bner et al., 2007).
Cells were fixed after either 2 or 6 hr and examined for Cherry
signal associated with GFP-Vpr signal within target cells. When
comparing control conditions to AMD3100-treated conditions,
we observed no difference in the Cherry signal associated with
the GFP-Vpr signal at 2 hr (data not shown). However, at 6 hr
the mean Cherry fluorescence signal associated with GFP-Vpr
puncta in AMD3100 conditions was 24% greater compared to
control conditions (Figure 6F). Thus, we observed an
AMD3100-sensitive loss of Cherry from viral puncta, with
kinetics similar to those observed using the Vpr-BlaM fusion
assays (Figure 1). In contrast to the HeLa cells, the appearance
of puncta with low levels of red fluorescence was less prominent
in CD4+ T cells. When considering the particles with the lowest
Vpr-GFP signal (which are more likely to be single particles),
6.5% of puncta in the untreated conditions had low Cherry fluo-
rescence (indicative of viral fusion) compared with 3.1% of
puncta in AMD3100-treated cells (Figure 6E). Therefore, we
conclude that AMD3100 inhibits the dissociation of Cherry signal
fromGFP-Vpr puncta in VS target cells after 6 h.We interpret this
as additionally supportive of viral membrane fusion occurring
from an intracellular location.
To directly visualize individual fusion events following cell-to-
cell transfer of HIV, we conducted live cell 3D spinning disk
microscopy on dual-labeled particles after they crossed the
VS, focusing our attention on tracking smaller viral puncta in
acceptor-cell endosomes rather than larger clusters of virus (Fig-
ure 6G). We imaged approximately 60 hr of live viral transfer
across the VS, tracking 225 viral particles. We collected data
on cells that had been in coculture over a wide time frameCell Host &(0–8 hr), with particular emphasis on later time points, when
acceptor cells had accumulatedmature virus particles (Figure 4).
Five putative fusion events were identified, all observed during
a 4–6 hr window following cell-cell mixing. These fusion events
were identified by a rapid loss of Cherry signal relative to neigh-
boring viral puncta; neighboring puncta displayed no such loss
of Cherry signal (Figures 6H–K). One putative fusion event
occurred in two stages over a period of 5 min, perhaps indicative
of two fusion events occurring from the same virus-containing
compartment (Figure 6I, Movie S1). In all cases, the Cherry fluo-
rescence of nearby particles remained stable, as did the GFP
signal, suggesting that our observations could not be explained
by photobleaching (Figure 6J). Other putative fusion events
showed a very rapid loss of Cherry (Figure 6K). Four of the five
putative fusion events exhibited a loss of more than 80% of the
Cherry signal, while a fifth event exhibited a loss of 50% of the
signal and then stabilized. We determined the distance of each
fusion event from the center of the Gag synaptic button and
mapped them schematically on a diagram of two synapsing
cells. This map depicts our finding that four of the five fusion
events occurred within intracellular compartments, microns
away from the synaptic button, and one occurred in closer
proximity to the VS (Figure 6L). Although the detection of fusion
at a distance from the synaptic button suggests these particles
do not fuse at the synaptic interface, it should be noted that
intense fluorescence from the donor cell could obscure the
visualization of dim fusion events near the synaptic junction.
DISCUSSION
To better understand how virological synapse-mediated infec-
tion differs from cell-free infection, we have followed the fate of
viral material that is transferred across synapses into target
CD4+ T cells. An earlier investigation showed that HIV-1 localizes
in trypsin-inaccessible intracellular compartments shortly after it
moves across the VS (Blanco et al., 2004; Chen et al., 2007).
Although the exact nature of this compartment is unknown,
recent data suggest that HIV-1 is transferred to nonlysosomal
compartments (Bosch et al., 2008) (G.P.M., B.M.D., and
B.K.C., unpublished data). This suggests that, following transfer
across the VS, HIV-1 can access a compartment in acceptor
CD4+ T cells that is compatible with maturation and fusion.
Given the tight temporal linkage of virus assembly with internal-
ization into the target cell, we found that the internalized viral
particles are initially immature and nonpermissive for viral
membrane fusion. Following a delay that included HIV-1
protease-dependent processing, we observed efficient viral
membrane fusion. Overall, our study supports a model whereby
the process of particle maturation is critical for the activation of
viral membrane fusion following transfer across a virological
synapse (Figure 7).
Because virus particle morphogenesis and transfer into
a target cell occur almost simultaneously, the maturation of
HIV-1 particles occurs within the confines of an endocytic
compartment. Compelling studies by the Aiken and Murakami
groups have found that particle fusogenicity is tightly linked
with the maturation state of the virus particle when considering
cell-free virus particles (Murakami et al., 2004; Wyma et al.,
2004). Our study places this model of maturation-induced fusionMicrobe 10, 551–562, December 15, 2011 ª2011 Elsevier Inc. 557
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Figure 6. Fusion of HIV-1 from Endosomes Following Transfer across the Virological Synapse
(A) Schematic depiction of HIVGag-iCherry/GFP-Vpr during cell-free fusionwith a HeLa CD4+ cell. In amature virus particle, Cherry fluorescent protein is cleaved
from Gag monomers but remains within the virus particle. Upon viral membrane fusion, the Cherry signal diffuses away while the GFP-Vpr remains associated
with the viral core.
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Figure 7. Model for Maturation-Induced Fusion at the Virological Synapse
(A) In the steady state, an HIV-1 infected T cell has a diffuse distribution of Env and Gag.
(B) The engagement of Env on the infected donor cell, with CD4 on the target cell, induces an adhesion event and results in the recruitment of Gag, Env, and CD4
to the VS.
(C) An endocytic event is triggered resulting in CD4-dependent uptake of immature virus into acceptor cell intracellular compartments.
(D) Bound to CD4, virus particles undergo protease-dependent maturation over time.
(E) Viral particle maturation triggers viral membrane fusion, releasing the capsid to the cytoplasm.
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Endosomal HIV Fusion after Virological Synapseinto a unique context where maturation occurs after the virus has
already engaged CD4 and is sequestered within an internal
compartment. When reconsidered in this manner, the proteolytic
maturation of the HIV-1 particle plays a dominant role in regu-
lating the fusogenicity of the virus particle so that it occurs with
a set time delay after synaptic transfer.
The intra-endosomal maturation of virus particles could
directly affect the susceptibility of viral membrane fusion to
neutralizing antibodies. Although many broadly neutralizing
monoclonal antibodies can block VS-promoted viral infection
(Chen et al., 2007; Martin et al., 2010), we have shown that poly-
clonal antibodies from patient sera can only partially block VS-
promoted viral fusion (Figure 2) and productive infection (Hu¨bner
et al., 2009), while maintaining strong inhibitory activity against
cell-free virus. This implies that a subset of antibodies within
patient sera block cell-free fusion more efficiently than VS-
induced fusion. In further agreement with this notion, recent
studies have identified a monoclonal antibody that neutralizes
cell-free infection with much greater efficiency than VS-
promoted infection (N. Durham and B.K.C., manuscript in prep-
aration). Because Env epitopes exposed on the surface of the
cell will be nonfusogenic, they may be less likely to react with
antibodies that target epitopes associated with mature, cell-
free virions (Figure 7). The initial engagement of Env and CD4(B and C) HeLa CD4+ cells were treated with HIV Gag-iCherry/GFP-Vpr (500 ng/m
used to measure the Cherry signal associated with the GFP signal. Results are sh
each particle (C). Control mean, 48.5; AMD3100 mean, 58.4; n = 1,416; p < 0.00
(D) Schematic depiction of HIV Gag-iCherry/GFP-Vpr following transfer across
fusion.
(E and F) Jurkat T cells expressing HIV Gag-iCherry and GFP-Vpr were cocultured
trypsinized. Primary CD4+ T cells were purified by FACS sorting and imaged usi
Cherry signal associated with the GFP signal in blue-labeled acceptor cells. R
associated with each particle (F). Control mean, 94.7; AMD3100 mean, 117.3; n
(G–L) Spinning-disk confocal live-cell imaging of particle fusion at the VS. A cotran
line) (left) (G). Several particles were chosen for tracking (particles a, b, and c).
(G, right) of a tracking period is shown, and a series of frames for the three partic
(K and L) A putative single viral membrane fusion event showing the rapid loss of C
the approximate localization, relative to VS, that 5 of 225 fusion events transferre
Cell Host &occurs during synapse formation, where viral assembly is subse-
quently recruited to the site. In this early stage, Env is held in
a prefusogenic conformation that does not induce cell-cell
fusion. It follows that CD4-Env engagement is not the immediate
driving force that activates viral membrane fusion during VS-
mediated infection; rather, it is more likely that the maturation
process occurring within the virus particle triggers particle
fusogenicity. Thus, even if antibodies can gain access to the
endocytic compartment, the relevant viral epitopes may be
hidden, sterically obstructed by the preformed Env/CD4 inter-
action, or only very transiently exposed when viral membrane
fusion is activated by particle maturation. This unique order of
events during VS-mediated infection may explain how VSs
exhibit distinct sensitivity to patient neutralizing antibodies.
The cellular localization of HIV-1 fusion during infection with
cell-free virus remains a subject of intense study. Unlike
pH-dependent viruses such as alphaviruses and flaviviruses,
HIV-1 undergoes a pH-independent viral membrane fusion
(McClure et al., 1988; Sa´nchez-San Martı´n et al., 2009; Stein
et al., 1987). While early literature suggested that the plasma
membrane is the primary site of viral fusion, more recent
evidence suggests that HIV-1 fusion can occur in an endosomal
compartment. A compelling study by Miyauchi et al. used C52L,
a late-stage inhibitor of viral membrane fusion, in combinationl) as described in Experimental Procedures, and automated image analysis was
own on a single-particle basis (B) or as the mean Cherry signal associated with
1.
the VS. After transfer, particles undergo maturation and then viral membrane
with CellTracker Blue-labeled primary CD4+ T cells for 5 h. The cells were then
ng confocal microscopy. Automated image analysis was used to measure the
esults are shown on a single particle basis (E) or as the mean Cherry signal
= 382; p < 0.001.
sfected Jurkat T cell is shown forming a VSwith an acceptor CD4+ T cell (dotted
An extended focus view of the particles at the beginning (G, center) and end
les is shown in (H). Particles a and b are quantitated in (I and J), respectively.
herry signal from the viral particle (K). The two-dimensional diagram in (L) shows
d particles during live cell imaging. See also Movie S1.
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portion of HIV-1 fusion can occur from an intracellular compart-
ment in HeLa and T cell line models of infection (Miyauchi et al.,
2009). Intriguingly, the majority of the fusion events imaged by
Miyauchi et al. were suggested to occur at endocytic locations,
not the plasma membrane. These results strongly suggest that
endocytic compartments can serve as an efficient intermediate
state during viral entry, even with cell-free viral innoculums.
The localization of HIV-1 fusion following transfer across the
VS appears to occur predominantly through an endocytic
pathway. We have previously documented the rapid transloca-
tion of HIV-1 within the target cell to a location distal to the
synaptic button. Given that the time delay for particle fusion is
on the order of 2 hr, it is likely that most fusion occurs from endo-
somes that are physically distant from the synaptic button.
Indeed, our single-particle imaging experiments found that four
of five single-particle fusion events occurred at a distant site.
Particle maturation and fusion in the target cell endosomes fol-
lowed similar protease-sensitive kinetics, further suggesting
that the viral particles do not fuse predominantly at the synaptic
junction. The time delay for particle maturation is consistent with
reports that HIV-1 maturation takes place over a period of hours
(Mervis et al., 1988; Pettit et al., 1994). It is attractive to speculate
that endocytic entry may allow the released core to find itself in
a position in the cell that favors the subsequent steps of
uncoating, reverse transcription, and nuclear import.
Transmission electron micrographs (TEM) of T cell virological
synapses have revealed nascent, crescent-shaped viral buds,
directly apposed to the target cell membrane without particles
found in the synaptic space (Hu¨bner et al., 2009). Other TEM
images of synapses show free virus particles in a space between
donor and target cells (Jolly et al., 2004). It is possible that the
latter images depict distinct synaptic structures, which can
form between chronically infected cells that have accumulated
virions at the cell surface. Using acutely transfected donor cells
to form synapses, we found that the vast majority of virus
entering cells is immature, suggesting that newly budded virus
particles internalized are very rapidly.
The regulation of Env fusogenicity during synapse-mediated
infection is critical because it allows the virus to transfer from
cell to cell in a conformation immunologically distinct from cell-
free virus. It also allows Env to remain in a prefusogenic state
during synapse formation. Thus, the virological synapse does
not merely provide an adhesive contact to concentrate cell-
free virus but also provides a unique method of regulating the
exposure of sensitive fusogenic epitopes, revealing them only
transiently within a protected, fusion-competent compartment.
Because antibodies are likely to target epitopes on mature
cell-free virus, conformational masking of these fusogenic
epitopes on the cell-surface may allow cell-surface Env to
escape detection by these antibodies. Future vaccine efforts
may be designed to specifically target epitopes that block
synapse formation at the surface of the infected T cell.EXPERIMENTAL PROCEDURES
Viral Constructs and Preparation of Viral Particles
HIV Gag-iGFP and HIV Gag-iCherry, infectious variants of pNL4-3, have
a fluorescent protein inserted between the matrix and capsid domains of560 Cell Host & Microbe 10, 551–562, December 15, 2011 ª2011 ElsGag (Hu¨bner et al., 2007). pEGFP-Vpr, a gift of Dr. Warner Greene (UCSF,
San Francisco, CA), and pmm310, a gift of Dr. Michael Miller (Merck Research
Laboratories), are available at the AIDS Research and Reference Reagent
Program (Cat#11386 and Cat#11444, respectively). HIV Gag-iGFP Pr(-) and
HIV Gag-iCherry Pr(-) were made by site-directed mutagenesis and are
protease catalytic mutants carrying a double-alanine (D25A/T26A) mutation
(Loeb et al., 1989). pNL4-3 MA/p6 was a gift of Christopher Aiken (Vanderbilt
University, Nashville, TN). Viral particles were produced using standard
calcium phosphate-mediated transfection of 293T cells (Pear et al., 1993).
Where noted, viral particles were produced in the presence of 2 mM Indinavir
(AIDS Research and Reference Reagent Program, Division of AIDS, NIAID,
NIH). Viral supernatants were quantitated by p24 ELISA and routinely yielded
p24 concentrations of 400–1,000 ng/ml.
Cells and Tissue Culture
Human CD4+ T cell lines Jurkat CE6.1 and MT4 were obtained from the
American Type Culture Collection (ATCC, Manassas, VA) and grown in Jurkat
culture media (RPMI 1640, 10% fetal bovine serum, 100 units/ml penicillin, and
100 mg/ml streptomycin). Human CD4+ T cells were purified by negative selec-
tion using a CD4+ T cell isolation kit II (Miltenyi Biotec, Auburn, CA) from buffy
coats obtained from blood donors at the New York Blood Center (Long Island
City, NY). Jurkat T cells were nucleofected using program S-18 (Lonza,
Walkersville, MD). MT4 cells and primary CD4+ cells were labeled, as noted,
by minor modification of the manufacturer’s protocol. Incubation of cells at
37C for 6 min in 0.7 mM DDAO Far Red or 30 min in 10–20 mM CellTracker
Blue gave optimal labeling.
Quantitation of Viral Membrane Fusion by the BlaM Assay
Cell-free viral fusion was quantitated as described (Cavrois et al., 2002).
Briefly, HIV-1 virus was produced by cotransfecting 293T cells with wild-
type proviral DNA (pNL4-3) and a plasmid (pMM310) that encodes
b-lactamase fused to the amino terminus of Vpr at a 3:1 ratio. Fusion assays
with cell-free virus were performed by adding virus (30 ng) to 2 3 105 cells in
a volume of 200 ml for the indicated amount of time. Cells were washed and
loaded with BLaM substrate CCF2-AM (1.5 mM) for 90 min at 25C. Cells
were then washed and incubated at 18C in CO2-independent media for
12 hr to allow for substrate cleavage. Finally, cells were washed in PBS, fixed
in 3.7% formaldehyde, and read on an LSR II flow cytometer (Becton
Dickinson, Franklin Lakes, NJ). Cleavage of CCF2-AM was determined
by exciting cells with a 405 nm laser and recording emission at 450 nm
(+/ 50 nm) and 525 nm (+/ 50 nm). Flow cytometry data was exported
and analyzed using FlowJo software (Tree Star, Ashland, OR). Gates were
set using untransfected cocultures. All conditions were background-sub-
tracted. In each experiment, control conditions were normalized to 100%
and experimental conditions were expressed as a percentage of control.
To assess cell-mediated fusion, 73 106 Jurkat T cells were transfected with
pNL4-3/Vpr-BLaM (30 ng) at a 3:1 ratio. After 24 h, transfected Jurkat cells
were purified by Ficoll density gradient centrifugation and used as donor cells.
These donor cells weremixedwith Far Red-labeled CD4+ cells at a 2:1 ratio for
the indicated amount of time. Cell cultures were then trypsinized, loaded with
CCF2-AM, and processed for flow cytometry as described above.
Viral Particle Maturation Assays as Assessed by p17 Staining
Jurkat T cells were transfected with HIV Gag-iGFP and mixed with Far Red-
labeled CD4+ T cells; viral transfer was quantitated as described previously
(Chen et al., 2007). To measure the fraction of mature virus in acceptor cells,
trypsinized cocultures were fixed in 3.7% formaldehyde, permeabilized in
0.05% saponin, and stained with a monoclonal antibody that recognizes p17
only in the context of mature virus (Ono et al., 2000; Zhou and Resh, 1996). p17
staining was detected with a PE-labeled secondary antibody that allowed for
simultaneous detection of viral transfer (GFP) and maturation (PE).
Viral Particle Maturation Assays as Assessed by FRET
For analysis of cell-free virus, 293T cells were cotransfected with HIV Gag-iGFP
and HIV Gag-iCherry at a 1:1 ratio. Filtered viral supernatant was spotted onto
poly-L-lysine coated glass coverslips and allowed to adhere for 15 min. Viral
particles were fixed in 3.7% paraformaldehyde at room temperature for
15 min, rinsed with PBS, and mounted onto glass slides with ProLong Goldevier Inc.
Cell Host & Microbe
Endosomal HIV Fusion after Virological Synapse(Invitrogen, Carlsbad, CA). To measure particle maturation in acceptor cells
following transfer across the VS, Jurkat cells were cotransfected with HIV Gag-
iGFP andHIVGag-iCherry at a 1:1 ratio. These cells weremixedwithCellTracker
Blue (Invitrogen)-labeledprimaryCD4+Tcells at a 2:1donor:acceptor cell ratio in
the presence of AMD3100. Intracellular viral particles were identified in an auto-
mated fashionbasedon their colocalizationwith thecytoplasmicdyeCellTracker
Blue and confirmed visually in all three dimensions. Viral particles were imaged
using a Leica SP5 DMI confocal microscope. Excitation lasers were 488 nm
(GFP) and 561 nm (Cherry). Emissions were captured between 500 and
580 nm (donor) and between 590 and 650 nm (acceptor and FRET). Donor and
acceptor bleedthrough constants were 2.7% and 10.4%, respectively. Normal-
ized FRET values were calculated as described previously (Xia and Liu, 2001).
Monitoring Viral Membrane Fusion by Live Cell Imaging
For analysis of cell-free fusion, 293T cells were cotransfected with HIV Gag-
iCherry and GFP-Vpr at a 3:1 ratio as described above. Approximately
500 ng/ml of filtered viral supernatant was added to adherent HeLa CD4+ cells
for 2 hr at 17C, a temperature that allows for binding but not fusion of the virus
(Markosyan et al., 2005). Cells were then washed gently and incubated at 37C
for 2 hr, fixed, and mounted on glass slides as described above. Analysis of
viral membrane fusion was performed using Volocity image analysis software
(PerkinElmer, Waltham,MA). Viral particles were identified using an automated
image segmentation process that identified particles with amean GFP fluores-
cence at least 30-fold over background. To quantitatemembrane viral fusion in
T cell cocultures, Jurkat T cells were cotransfected with HIV Gag-iCherry and
GFP-Vpr at a 3:1 ratio and mixed with CellTracker Blue-labeled primary CD4+
T cells. Cells were incubated together for the indicated amount of time, trypsi-
nized, sorted by flow cytometry (FACSAria, Becton Dickinson), and fixed on
poly-L-lysine-coated glass coverslips. Viral particles were identified using
the same criteria used in cell-free experiments, with the additional requirement
that particles had a mean blue fluorescent signal at least 200-fold over back-
ground, indicative of their association with the cytoplasm of a target cell. After
identification, all particles were visually inspected in three dimensions to
confirm localization in acceptor cells. To image live viral fusion in acceptor cells
engaged in a virological synapse, Jurkat T cells were cotransfected with HIV
Gag-iCherry and GFP-Vpr at a 3:1 ratio and mixed with primary CD4+
T cells in CO2-independent media (Invitrogen), supplemented with 10% FBS
and IL-2 (10 units/ml). Cells were loaded into Ibidi imaging chambers (Ibidi,
Verona, WI) and imaged for up to 1 hr at various time points after initiating
coculture. Cells were imaged at 37C on an inverted optical microscope
(iX71 Olympus, Center Valley, PA) equipped with a 603, 1.42 NA oil immersion
objective (UPlanApo N, Olympus), piezoelectric z-stage (Mad City Labs, Mad-
ison, WI), spinning disk confocal unit (CSU-10, Yokagawa, Japan) using a 405/
488/568/647 nm quad-band dichroic mirror (Semrock, Rochester, NY), and an
EM-CCD camera (iXon+ 897, Andor Technologies, Ireland) to allow rapid 3D
time-lapse confocal imaging. To further reduce 3D imaging time to 1.5–3 s,
we reduced the active area of the EM-CCD to the cell-pair region ( one-
quarter of the 512 3 512 pixel area of the EM-CCD). A multiline ArKr ion gas
laser (Innova 70C, Coherent, Santa Clara, CA) paired with an acousto-optic
tunable filter (AOTF) (Andor Technologies) allowed fluorescence excitation,
with microsecond wavelength switching between 488 and 532 nm (for GFP
and iCherry, respectively) at < 1 mW. The AOTF further shuttered the laser
during the 10–20 ms EM-CCD readout to reduce photobleaching and photo-
toxicity. iGFP and iCherry fluorescence emission were separated using an
OptoSplit II image splitter (Cairn, Kent, UK) equipped with a 570 nm long-
pass dichroic mirror (Chroma, Rockingham, VT), and were filtered by 525/50
and 609/54 nm bandpass filters (Semrock) respectively. Most electronics
and acquisition were coordinated by the Andor iQ v1.8 software.
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